Podcasts about cardiologie

This week we review a study assessing the impact of bundle branch block (BBB) on exercise tolerance amongst the single ventricle Fontan patient cohort. Why would this be associated with worse outcomes for exercise? How should the cardiologist use this datum of BBB in a single ventricle patient to inform clinical decision making in this patient group? Why is cardiac resynchronization therapy so challenging in this patient group? Dr. Omar Meziab of The University of Arizona shares his deep insights this week. https://doi.org/10.1007/s00246-024-03500-1

In this replay episode from 2023, we return to the world of ACHD when we review a recent German research paper on the prevalence of PTSD symptoms amongst the ACHD patient group. How common is this type of symptom observed in the ACHD patient group? What contributes to the high prevalence (17-20.5%) described in this work? What are the benefits of 'embedding' a mental health care worker in the ACHD clinic/program? What strategies can be employed in pediatric cardiology to potentially mitigate PTSD symptoms in our future ACHD patients? These are amongst the many topics reviewed this week with the former Mount Sinai ACHD program clinical social worker, Ms. Meredith Kalbacker who also comments on this week's work. DOI: 10.1016/j.amjcard.2023.06.087For those interested, the book referenced by Ms. Kalbacker, Healing Hearts and Minds, can be purchased on Amazon:https://www.amazon.com/Healing-Hearts-Minds-Holistic-Congenital/dp/0197657281

This week we review a recent study assessing the rate of hematochezia seen in children following neonatal congenital heart surgery, predominantly for aortic obstruction such as in HLHS. How often is this sign observed in this patient group and what percentage of these patients have actual necrotizing enterocolitis (NEC)? Are there any modifiable risk factors for NEC? How can these data help clinicians separate out those with more benign forms of hematochezia from those with NEC and how might this improve care for this patient group? These are amongst the questions reviewed this week with the work's first author, University of Michigan Assistant Professor of Pediatrics, Dr. Courtney Strohacker. DOI: 10.1007/s00246-024-03485-xFor those interested in pediatric podcasts, please take a look at this list of the 'top 15' pediatric topic podcasts - we are #4 in pediatrics for 2025!https://podcast.feedspot.com/pediatric_podcasts/

This week we review a report from the teams at University College, Dublin and Texas Children's Hospital about a collaborative approach to education in which two centers across the globe participate in a shared fellow learning conference. In this conference which is aimed at fellow education, topics are chosen and discussed with facilitated learning from faculty at both sites. What can be gained for fellows on opposite sides of the Atlantic that cannot be learned from exposure to just their one site? How did this approach help fellows learn about how to deal with uncertainty in decision making? How did this trans-continental learning approach enhance patient and team communication? These are amongst the many questions posed to senior cardiologist and senior author of this week's work, Professor Colin McMahon of University College, Dublin, Ireland.   ·         DOI: 10.1007/s00246-024-03469-x

This week we review a recent review paper on newest innovations and literature on pacing in pediatric patients and learn a bit about such diverse pediatric pacing topics as:Use of the Medtronic Micra device in an off-label manner for epicardial pacing in small infantsNovel, less invasive approaches to placing epicardial leads in small childrenThe role of leadless pacing in the pediatric or CHD patientConduction system pacing in 2025 in the congenital patientThe above are amongst the potpourri of pacing topics that we review with noted congenital electrophysiologist, Dr. Charles Berul of Children's National Hospital in Washington, DC in a co-branded episode with the SADS Foundation. For more information on SADS, please go to their website: SADS.ORG.DOI: 10.1016/j.hrthm.2024.02.011

Lésions des ligaments, luxation de la rotule, arthrose… Le genou étant une articulation particulièrement sollicitée au quotidien, nombreuses sont les pathologies pouvant l'affecter. Or, en l'absence de prise en charge adaptée, ces pathologies peuvent avoir des répercussions sur tout le squelette.  Quelles sont les pathologies du genou les plus fréquentes ? Comment les prévenir ? Quels sont les facteurs de risque susceptibles de fragiliser les genoux ? Quelles sont les prises en charge existantes ?  Dr Patrick Djian, chirurgien orthopédiste et traumatologue à la Clinique Nollet, à Paris. Enseignant à la Faculté Paris Descartes et à l'INSEP (Institut national du sport, de l'expertise et de la performance) Pr Mouhamadou Habib SY, enseignant-chercheur, chirurgien orthopédiste. Directeur de l'Institut d'Orthopédie Seydi Djamil (IOSD) à Dakar. ► En fin d'émission, nous parlons du Mois du Cœur, initiative lancée en 2024 par la Fondation Cœur & Recherche pour sensibiliser à un enjeu de santé publique majeur : les maladies cardiovasculaires qui représentent la première cause de mortalité dans le monde. Interview du Pr Ariel Cohen, chef de service de Cardiologie à l'Hôpital Saint-Antoine, Hôpital Tenon et président de la Fondation Cœur et Recherche.   Programmation musicale :► Ruger ; Tiwa Savage – Toma toma ► Dowdelin – Sonmèy.

Lésions des ligaments, luxation de la rotule, arthrose… Le genou étant une articulation particulièrement sollicitée au quotidien, nombreuses sont les pathologies pouvant l'affecter. Or, en l'absence de prise en charge adaptée, ces pathologies peuvent avoir des répercussions sur tout le squelette.  Quelles sont les pathologies du genou les plus fréquentes ? Comment les prévenir ? Quels sont les facteurs de risque susceptibles de fragiliser les genoux ? Quelles sont les prises en charge existantes ?  Dr Patrick Djian, chirurgien orthopédiste et traumatologue à la Clinique Nollet, à Paris. Enseignant à la Faculté Paris Descartes et à l'INSEP (Institut national du sport, de l'expertise et de la performance) Pr Mouhamadou Habib SY, enseignant-chercheur, chirurgien orthopédiste. Directeur de l'Institut d'Orthopédie Seydi Djamil (IOSD) à Dakar. ► En fin d'émission, nous parlons du Mois du Cœur, initiative lancée en 2024 par la Fondation Cœur & Recherche pour sensibiliser à un enjeu de santé publique majeur : les maladies cardiovasculaires qui représentent la première cause de mortalité dans le monde. Interview du Pr Ariel Cohen, chef de service de Cardiologie à l'Hôpital Saint-Antoine, Hôpital Tenon et président de la Fondation Cœur et Recherche.   Programmation musicale :► Ruger ; Tiwa Savage – Toma toma ► Dowdelin – Sonmèy.

This week we step back in time 3 years ago to review an important cardiac MRI report on Fontan geometry and hemodynamics as measured by computational fluid dynamic analysis. How do factors like Fontan geometry or 'power loss' relate to quality of life for the Fontan young adult patient? How do these data inform imaging in the operating room during these palliations? We speak with the first author of this work, Associate Professor of Pediatrics at U. Penn, Dr. Laura Mercer-Rosa about this important and intriguing work. https://doi.org/10.1016/j.athoracsur.2022.01.017

This week we review a work from the department of cardiology and department of cardiac surgery at Boston Children's Hospital on late hypertension in patients following coarctation repair. Late hypertension has been associated previously with late transverse aortic arch Z score but can this be predicted by the immediate postoperative transverse aortic arch Z score also? What factors account for late hypertension in the coarctation patient? Should more patients have their aorta repaired from a sternotomy? Dr. Sanam Safi-Rasmussen, who is a PhD candidate at Copenhagen University, shares her insights from a work she performed while a research fellow at Boston Children's Hospital. DOI: 10.1016/j.jtcvs.2024.08.049

This week we delve into the world of cardiovascular surgery and general cardiology when we review a recent report from UVA on the topic of feeding around the time of neonatal heart surgery. Does preoperative oral feeding improve the chances for 'tube-free' enteral feeds at discharge after heart surgery in small infants? Why might oral feedings improve the chances of discharge oral feedings? How should clinicians think about the known benefits of early CHD surgery for some CHD lesions with the benefits of oral feedings? Dr. Aseel Dabbagh of Children's Mercy Hospital in Kansas City shares her insights into these and other questions. DOI: 10.1007/s00246-024-03750-z

❤️ Bonjour,Bienvenue dans cet épisode consacré à l'anatomie du cœur !

This week we review a recent ACTION NETWORK project comparing outcomes of children with CHD who undergo VAD support in comparison to those children with VAD's who do not have CHD. How do morbidity and mortality rates compare between these two cohorts? Why might there be differences in outcomes between these two groups? How are heart failure and transplant cardiologists going to improve outcomes in complex CHD VAD patients in the future? How can all cardiologists make more timely referrals to heart failure and transplant cardiologists for their congenital heart patients? Dr. Shahnawaz Amdani of the Cleveland Clinic provides many insights this week. DOI: 10.1016/j.jacc.2024.10.083

AVC, infarctus du myocarde, insuffisance cardiaque, hypertension artérielle… les maladies cardiovasculaires représentent, avec le cancer, les premières causes de mortalité chez les femmes. Pourquoi la prévention de l'hypertension artérielle reste un facteur essentiel de réduction des risques de maladies cardiovasculaires ? Comment la dépiste-t-on ? Peut-on arrêter ses médicaments sans avis médical, quand on est hypertendu ? Pr Roland N'Guetta, Cardiologue interventionnel à l'Institut de Cardiologie d'Abidjan. Président du Groupe de Recherche et d'Actions contre les Maladies Cardiovasculaires (GRAM). Ancien Président de la Société Ivoirienne de Cardiologie Retrouvez l'émission en entier ici : Questions de femmes : cardiologie au féminin

In this week's replay episode from 2023, we speak with Associate Professor of Pediatrics at Mount Sinai, Dr. Jennifer Cohen about a recent large scale Fetal Heart Society project she conducted on the topic of fetal ccTGA and outcomes. What observations in fetal life are associated with worse clinical outcomes? Why is it valuable to perform serial fetal echocardiograms in this patient group? How common are genetic or extracardiac abnormalities in this patient group? These are amongst the many questions reviewed with Dr. Cohen this week. DOI: 10.1161/JAHA.122.029706

Comme chaque vendredi, un médecin spécialisé répond aux questions des auditrices de Priorité Santé. Cette semaine, nous parlons de la santé cardiaque des femmes. AVC, infarctus du myocarde, insuffisance cardiaque, hypertension artérielle… les maladies cardiovasculaires représentent, avec le cancer, les premières causes de mortalité chez les femmes. Un cardiologue répond aux questions des auditrices de Priorité Santé.    Pr Roland N'Guetta, cardiologue interventionnel à l'Institut de Cardiologie d'Abidjan. Président du Groupe de Recherche et d'Actions contre les Maladies Cardiovasculaires (GRAM). Ancien président de la Société Ivoirienne de Cardiologie.    La palabre au féminin de Charlie Dupiot. Programmation musicale :► Amadeus – Legit► Sarah Lenka – Isha.

Comme chaque vendredi, un médecin spécialisé répond aux questions des auditrices de Priorité Santé. Cette semaine, nous parlons de la santé cardiaque des femmes. AVC, infarctus du myocarde, insuffisance cardiaque, hypertension artérielle… les maladies cardiovasculaires représentent, avec le cancer, les premières causes de mortalité chez les femmes. Un cardiologue répond aux questions des auditrices de Priorité Santé.    Pr Roland N'Guetta, cardiologue interventionnel à l'Institut de Cardiologie d'Abidjan. Président du Groupe de Recherche et d'Actions contre les Maladies Cardiovasculaires (GRAM). Ancien président de la Société Ivoirienne de Cardiologie.    La palabre au féminin de Charlie Dupiot. Programmation musicale :► Amadeus – Legit► Sarah Lenka – Isha.

Saviez-vous que l'heure à laquelle vous prenez votre café à une incidence sur votre santé ? Figurez-vous qu'une étude de la Société Européenne de Cardiologie révèle que les bénéfices du café sur la santé existent uniquement pour ceux qui en consomment... avant midi.

Saviez-vous que l'heure à laquelle vous prenez votre café à une incidence sur votre santé ? Figurez-vous qu'une étude de la Société Européenne de Cardiologie révèle que les bénéfices du café sur la santé existent uniquement pour ceux qui en consomment... avant midi.

Quels sont les messages essentiels à faire passer en matière de prévention des maladies cardiovasculaires ?    Pr Kouadio Euloge Kramoh, Directeur Général de l'Institut de Cardiologie d'Abidjan (Côte d'Ivoire). Past-Président de la Société Ivoirienne de Cardiologie. Past-Président des Sociétés de Cardiologie de l'Afrique de l'Ouest et du Centre. Co-président du groupe de cardiologie tropicale de la SFC   Retrouvez l'émission en intégralité iciCardiologie : spécificités en Afrique subsaharienne

À l'occasion des 35è Journées européennes de cardiologie qui se tiennent du 15 au 17 janvier 2025 au Palais des Congrès de Paris, nous faisons un point sur les spécificités en Afrique subsaharienne (formation, épidémiologie, plateau technique, accès aux soins), en réunissant 3 spécialistes venus partager leurs expériences respectives. Pr Kouadio Euloge Kramoh, directeur général de l'Institut de Cardiologie d'Abidjan (Côte d'Ivoire). Past-Président de la Société Ivoirienne de Cardiologie. Past-Président des Sociétés de Cardiologie de l'Afrique de l'Ouest et du Centre. Co-président du groupe de cardiologie tropicale de la SFC  Pr Khaled Boye, chef du service de Chirurgie cardiovasculaire au Centre National de Cardiologie, Nouakchott, Past président de la Société Mauritanienne de cardiologie  Dr Jean-Jacques Monsuez, rédacteur en chef d'Archives des Maladies du Cœur et des Vaisseaux (journal de formation continue de la Société française de cardiologie), co-président du groupe de cardiologie tropicale de la SFC, Cardiologie, Hôpital René-Muret à Sevran, France. ►  En fin d'émission, nous retrouvons la chronique sexualité de Noëlle Cayarcy, sexologue à Paris.Programmation musicale :► Louane – Donne-moi ton cœur► Asake, Wizkid – MMS.

À l'occasion des 35è Journées européennes de cardiologie qui se tiennent du 15 au 17 janvier 2025 au Palais des Congrès de Paris, nous faisons un point sur les spécificités en Afrique subsaharienne (formation, épidémiologie, plateau technique, accès aux soins), en réunissant 3 spécialistes venus partager leurs expériences respectives. Pr Kouadio Euloge Kramoh, directeur général de l'Institut de Cardiologie d'Abidjan (Côte d'Ivoire). Past-Président de la Société Ivoirienne de Cardiologie. Past-Président des Sociétés de Cardiologie de l'Afrique de l'Ouest et du Centre. Co-président du groupe de cardiologie tropicale de la SFC  Pr Khaled Boye, chef du service de Chirurgie cardiovasculaire au Centre National de Cardiologie, Nouakchott, Past président de la Société Mauritanienne de cardiologie  Dr Jean-Jacques Monsuez, rédacteur en chef d'Archives des Maladies du Cœur et des Vaisseaux (journal de formation continue de la Société française de cardiologie), co-président du groupe de cardiologie tropicale de la SFC, Cardiologie, Hôpital René-Muret à Sevran, France. ►  En fin d'émission, nous retrouvons la chronique sexualité de Noëlle Cayarcy, sexologue à Paris.Programmation musicale :► Louane – Donne-moi ton cœur► Asake, Wizkid – MMS.

This week we review a recent report that asks the question, 'Do all infants who present with SVT require preventive anti-arrhythmic medical therapy?' Who might be a candidate for not using an anti-arrhythmia medication in infancy? What sort of parental education is needed to potentially not use medicine and how do patients not treated compare to those who were treated with anti-arrhythmics in regards to re-admission or presentation to the emergency department or development of tachycardia induced cardiomyopathy? How should parents assess their infants for SVT at home? How long should infants be monitored prior to discharge to home after a single uncomplicated episode of SVT? We speak with Assistant Professor of Pediatrics at Washington University and the first author of this week's work, Dr. Anthony Pompa. DOI: 10.1007/s00246-023-03263-1

This week we review a recent large scale, multicenter adult congenital heart study on outcomes of HLHS Fontan patients versus other single RV Fontan patients. How do the two groups compare in regards to thromboembolic risk, risk for arrhythmia or risk for death and heart transplantation? Why might there be differences between these single RV patient groups? How can these results inform management? We speak with Assistant Professor of Medicine and Pediatrics at The Icahn School of Medicine at  Mount Sinai, ACHD expert Dr. Kali Hopkins. doi: 10.1161/JAHA.124.034757. Epub 2024 Nov 27

Une étude menée par l'Institut national de la santé et de la recherche médicale (Inserm) a révélé que les cyclistes français ayant participé au Tour de France entre 1947 et 2012 bénéficient d'une espérance de vie supérieure de 6,3 ans par rapport à la population générale. Cette étude, présentée en 2013 lors du Congrès de la Société Européenne de Cardiologie à Amsterdam, a analysé les données de 786 cyclistes français, représentant environ 30 % des participants au Tour de France depuis la fin de la Seconde Guerre mondiale. Les résultats ont montré une mortalité globale inférieure de 41 % chez ces cyclistes par rapport à la population générale. Plus précisément, la mortalité par cancer était réduite de 44 %, celle liée aux maladies cardiovasculaires de 33 %, et celle due aux affections respiratoires de 72 %. Plusieurs facteurs peuvent expliquer cette longévité accrue : 1. Hygiène de vie saine : Les cyclistes professionnels adoptent généralement des habitudes de vie saines, notamment une alimentation équilibrée et une activité physique régulière. De plus, la majorité d'entre eux ne fument pas, réduisant ainsi les risques de maladies liées au tabagisme. 2. Pratique sportive continue : Beaucoup de ces athlètes maintiennent une activité physique même après la fin de leur carrière professionnelle, ce qui contribue à une meilleure santé globale et à une réduction des risques de maladies chroniques. 3. Accès aux soins médicaux : Le statut socio-économique souvent favorable des cyclistes professionnels leur permet un meilleur accès aux soins de santé, facilitant la prévention et le traitement précoce de diverses affections. Concernant l'impact du dopage, l'étude a examiné les taux de mortalité sur différentes périodes correspondant à l'utilisation de substances spécifiques : les années 1950-1960 (amphétamines), les années 1970-1980 (stéroïdes anabolisants) et les années 1990-2000 (EPO et hormones de croissance). Les résultats n'ont pas montré de variation significative de la mortalité entre ces périodes. Cependant, en raison du manque de données précises sur l'étendue réelle du dopage et de la nature des substances utilisées, il est difficile de tirer des conclusions définitives sur son impact à long terme sur la santé et la longévité des cyclistes. En conclusion, l'espérance de vie supérieure des cyclistes du Tour de France s'explique principalement par une hygiène de vie saine, une pratique sportive continue et un meilleur accès aux soins médicaux. Bien que le dopage ait été présent dans le cyclisme professionnel, les données actuelles ne permettent pas de déterminer son impact précis sur la longévité de ces athlètes. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

This week we delve into preventive cardiology with noted world authority, Associate Professor of Pediatrics, Dr. Carissa M. Baker-Smith of Nemours Health. In the present era, what roles do environment and social determinants of health play in cardiovascular disease? How should practitioners take a family history and how has the family history evolved in modern times? How can clinicians be sure that they are not 'missing' factors when they are trying to screen for cardiovascular disease risk in their patients? What are a few practical changes in how we speak with patients that we can all make to improve our understanding of our patients and their families? An important conversation this week with Dr. Baker-Smith.https://doi.org/10.1007/s11883-024-01232-4

This week we delve into the world of adult congenital heart disease to review the topic of liver disease in the Fontan patient and specifically, hepatocellular carcinoma (HCC). What is the prevalence of this disease in the Fontan single ventricle adult patient? How effective are scores like the MELD-XI or Fibrosis-4 Index at identification of HCC in the Fontan patient? How should the Fontan adult patient be surveilled for this form of cancer? What evidence is there that earlier identification of HCC is associated with better outcomes? What may prove to be the most important factor in protection of the liver in the Fontan patient? Dr. Yuli Kim, Director of the ACHD program at The University of Pennsylvania shares her deep insights this week into this important topic. DOI: 10.1093/eurheartj/ehad788

Près de 9 millions de personnes sont décédées d'une maladie cardiaque en 2019, selon l'OMS. Les maladies cardio-vasculaires représentent au total 16 % des décès, soit la principale cause de mortalité dans le monde. Ces maladies peuvent être liées à des comportements individuels comme le tabagisme ou la sédentarité ou associées à d'autres pathologies, comme le diabète ou l'obésité. À ces facteurs peuvent aussi s'ajouter d'autres causes, par exemple d'ordre environnemental (pollution atmosphérique).Pour prévenir des complications d'une maladie cardiaque, quels sont les premiers signes qui doivent pousser à consulter ? Pourquoi est-il essentiel de contrôler régulièrement sa pression artérielle ? Pr Roland N'GUETTA, Cardiologue interventionnel à l'institut de Cardiologie d'Abidjan et Président de la Société ivoirienne de cardiologieRetrouvez l'émission en entier ici :Santé cardiaque: un médecin vous répond en direct

This week we celebrate the life and career of Dr. Charles Mullins who passed this past week. Dr. Mullins was Professor of Pediatrics at Baylor College of Medicine and one of the pioneers in the world of congenital heart interventional cardiology. In today's episode we will listen back to an episode from 2021 from the SCAI 2021 meeting in which we interviewed Dr. Mullins and Dr. Julie Vincent (then Professor of Pediatrics at Columbia University). Drs. Mullins and Vincent discuss their lives as interventional cardiologists and also speak about the role that mentorship played in their long careers. Dr. Aimee Armstrong of Nationwide Children's Hospital also participates in this conversation. Following this interview replay with Drs. Mullins and Vincent, we speak with Dr. Frank Ing who is the Director of Pediatric Cardiology at UC Davis and the former director of the catheterization lab at Texas Children's and a former trainee and close friend of Dr. Mullins and his family. Dr. Ing shares his memories of training under Dr. Mullins, his thoughts on what was possibly Dr. Mullins' greatest professional contribution and finally speaks about what he learned about being a good mentor from his years with Dr. Mullins. 

This week we speak for the entire episode with award winning author Patricia Meisol about her recent book entitled: A Heart Afire: Helen Brooke Taussig's Battle Against Heart Defects, Unsafe Drugs, and Injustice in Medicine. We review Dr. Taussig's early life and the impact it had on her life. Why was there friction between Drs. Taussig and Blalock? What was Dr. Taussig's role in the establishment of the most stringent drug testing rules in the world today? What would Dr. Taussig consider to be her greatest achievement? Was Dr. Taussig the first in our field to understand the notion of social determinants of health? Ms. Meisol reviews this and more in our wide ranging conversation about the extraordinary Professor Helen Taussig. We also share a brief conversation of Dr. Taussig from 1977, speaking about her role in the development of the BTT shunt. For those interested, Ms. Meisel's book is available: https://bookshop.org/p/books/a-heart-afire-helen-brooke-taussigs-battle-against-heart-defects-unsafe-drugs-and-injustice-in-medicine-patricia-meisol/19955020?ean=9780262048521or wherever you get your books!

This week we enter the world of cardiac CT for congenital heart disease reviewing a recent report of a survey of congenital cardiologists who perform congenital heart CT scans. What have been the important trends seen in the past decade beyond expansion in the field in general? Why has the use of the CT scan grown at such a rapid clip? How much radiation does a present day CT scan represent for a patient? How are cardiology fellowships responding to the growing role of this modality in the field? How can we more properly assign accurate relative value units (RVU's) to the significant work effort involved in the performance and reporting of this novel modality. We speak with the first author of this week's work, Assistant Professor of Pediatrics at Weill Cornell, Dr. Rebecca Epstein.  doi: 10.1016/j.jcct.2024.02.002. Epub 2024 Feb 15.

This week we review a recent thought-provoking work on the topic of the dreaded 'pre-authorization' process for procedures being performed in the US. Are there data to support the costs in money and time associated with this process in the world of congenital cardiology? How often are authorizations denied in congenital cardiac cases? Is there any evidence that obtaining insurance pre-authorization improves outcomes? What is the impact of this process on healthcare equity? These are amongst the questions reviewed this week with Dr. Brian Marcus who is a cardiologist and critical care fellow at U. Wisconsin. DOI: 10.1007/s00246-023-03255-1

Pulmonary valve replacement following the arterial switch operation is rare. However, when necessary, how do techniques of transcatheter valve replacement fare for this indication? Why would average outcomes in this setting be less good than in the typical TPVR tetralogy of Fallot patient? How does the presence of stents in the pulmonary arteries in this patient group affect candidacy for TPVR? Are there ways to predict who might be a candidate for a TPVR vs. surgical PVR before coming to the catheterization lab? These are amongst the questions reviewed and posed to Dr. Stephen Nageotte who is the director of the cardiac catheterization laboratory at Loma Linda Children's Hospital in Loma Linda, California.  DOI: 10.1002/ccd.31152

This week we review a recent large scale study on catecholaminergic polymorphic ventricular tachycardia (CPVT) in children which is based on two large international registries. How do outcomes differ between those symptomatic CPVT patients treated with or without an ICD? Who amongst symptomatic CPVT pediatric patients likely warrant an ICD? What sort of ICD might be optimal - subcutaneous or transvenous? Are there ways to program ICD's in CPVT patients that may reduce inappropriate shocks? Why should the ICD be rarely employed in the CPVT pediatric patient? These are amongst the questions reviewed this week on the podcast. We speak with the work's senior author, Dr. Shubhayan Sanatani who is the chief of pediatric cardiology at BC Children's Hospital in Vancouver, British Columbia, Canada. doi: 10.1016/j.hrthm.2024.04.006. Epub 2024 Apr 7.

This week we delve into the worlds of cardiac critical care and neurodevelopment when we review a recent report from the team at Children's Hospital of Philadelphia assessing an association between postoperative opioid exposure in infants following CHD surgery and neurodevelopmental outcomes. What might be the biological basis for an association between these 2 factors? How confident can we be that opioid exposure is the factor of importance when there are so many co-variates and variables? We speak with outcomes research expert and interventional cardiologist Dr. Michael O'Byrne about this important and thought-provoking recent work.DOI: 10.1016/j.jacc.2024.06.033

0:00 Introducere și prezentarea Dr. Alexandra Mircea3:25 Evoluția dietei umane și impactul asupra sănătății dentare8:10 Legătura dintre sănătatea orală și bolile cardiovasculare15:30 Importanța propriocepției dentare și problemele implanturilor22:45 Conexiunea dintre postura corpului și alinierea dentară28:20 Impactul problemelor dentare asupra digestiei și nutriției35:15 Inovații în tehnologia dentară: scanări 3D și gutiere invizibile42:50 Rolul inteligenței artificiale în viitorul stomatologiei51:30 Importanța alinierii dentare la orice vârstă58:40 Discuție despre "mugurii de dinți" și regenerarea dentară1:05:15 Legătura dintre sănătatea orală și starea psihică1:12:30 Perspective asupra programelor naționale de sănătate dentară1:18:45 Sfaturi practice pentru îngrijirea dentară zilnică1:25:20 Abordarea holistică a sănătății și importanța prevenției1:31:00 Concluzii și recomandări finale IGDLCC înseamnă Informații Gratis despre Lucruri care Costă! Totul ne costă dar mai ales timpul așa că am făcut această serie pentru a mă informa și educa alături de invitați din domeniile mele de interes. Te invit alături de mine în această călătorie. Mi-am propus să mă facă mai informat și mai adaptat la schimbările care vin. Sper să o facă și pentru tine.

This week we listen in on a lecture by Assistant Professor of Pediatrics at the University of Pennsylvania, Dr. Christopher Janson, on the novel agent ivabradine. How does this agent work and in what circumstances can it be used in pediatric arrhythmia management? Is this safe to use for critical arrhythmias despite the fact that it is, at present, only available as an enteral agent? What is the proper dosing regimen with this medication? Dr. Janson answers these and many more questions about ivabradine in this lecture from the Pedirhythm XI conference in Rome, Italy on 9/20/24. 

Organe vital, le cœur humain est un muscle essentiel à la bonne circulation du sang dans le corps. Chaque minute, 5 litres de sang passent par le cœur. Que se passe-t-il quand celui-ci ne fonctionne plus correctement ? Quels sont les troubles pouvant l'affecter ? Quand faut-il envisager le recours à la chirurgie ?   Pr Paul Achouh, chef du service de chirurgie cardiaque de l'Hôpital Européen Georges Pompidou, APHP, à Paris. Professeur d'Université et chef adjoint du département médico-universitaire. Responsable de SOS Aorte Pr Roland N'Guetta, cardiologue interventionnel à l'Institut de Cardiologie d'Abidjan. Président du Groupe de Recherche et d'Actions contre les Maladies Cardiovasculaires (GRAM) Pr Claire Mounier-Véhier, cofondatrice d'Agir pour le Cœur des Femmes, cardiologue au CHRU de Lille et Professeure de médecine vasculaire à l'Université de Lille.Programmation musicale : ► Dino D'Santiago – Oh bahia► Nina Simone – Lova has been good to me.

Organe vital, le cœur humain est un muscle essentiel à la bonne circulation du sang dans le corps. Chaque minute, 5 litres de sang passent par le cœur. Que se passe-t-il quand celui-ci ne fonctionne plus correctement ? Quels sont les troubles pouvant l'affecter ? Quand faut-il envisager le recours à la chirurgie ?   Pr Paul Achouh, chef du service de chirurgie cardiaque de l'Hôpital Européen Georges Pompidou, APHP, à Paris. Professeur d'Université et chef adjoint du département médico-universitaire. Responsable de SOS Aorte Pr Roland N'Guetta, cardiologue interventionnel à l'Institut de Cardiologie d'Abidjan. Président du Groupe de Recherche et d'Actions contre les Maladies Cardiovasculaires (GRAM) Pr Claire Mounier-Véhier, cofondatrice d'Agir pour le Cœur des Femmes, cardiologue au CHRU de Lille et Professeure de médecine vasculaire à l'Université de Lille.Programmation musicale : ► Dino D'Santiago – Oh bahia► Nina Simone – Lova has been good to me.

In this week's replay episode from 2 years ago, we review the important topic of troponin levels in children. What is an abnormal high sensitivity troponin level in children and do the levels vary based upon the assay? What are the differences between high sensitivity troponin I and T levels? Are there differences between boys and girls? Why would using the 97.5%ile upper reference limit result in a more reliable 'line in the sand' in comparison with the more traditional, high sensitivity troponin level cut off of 99th%ile. These are amongst the questions we review with this week's author, Dr. J. Bill McEvoy, Professor of Preventive Cardiology at University of Galway, Ireland. DOI: 10.1161/CIRCULATIONAHA.122.063281

This week we listen in on a debate from the PICS 2024 Symposium that occurred two weeks ago in San Diego. Today's debate is between master surgeon, Professor of Surgery at UCLA, Dr. Glen S. Van Arsdell taking the position of superiority of primary TOF repair and going up against Dr. Van Arsdell is noted master interventional cardiology expert, Professor of Pediatrics at Baylor College of Medicine, Dr. Athar M. Qureshi. Prepare for a spirited 'debate' between these two experts in their field. Apologies in advance for some sound deficiencies but the orators can be heard clearly enough to allow for an engaging back and forth and learning experience. Has either speaker swayed you? Take a listen!

This week we speak with noted interventional cardiologist Dr. Shyam Sathanandam of LeBonheur Children's Hospital in Memphis, TN about novel, 'off-label' uses of the Amplatzer Piccolo device in children. In what sorts of lesions does Dr. Sathanandam believe this device offers distinct advantages for vascular closure? What is the feature of this device that allows it to work for small defect closure so effectively and safely? Are there any new changes coming to this device or the delivery system for PDA closure in the premature infant? These are amongst the questions and topics reviewed with our guest this week!https://doi.org/10.1080/14796678.2024.2355057

This week's episode reviews the notion of the underrepresented in medicine physician and the decision to pursue pediatric cardiology. How would improved representation amongst the congenital heart work force result in better outcomes for patients? How does a diverse workforce foster improved communication with patients? What are some practical steps that can be employed to improve representation in the field? We speak with third year cardiology fellow, Dr. Ogochuckwu M Ezeoke Cox, MD of C.S Mott Children's Hospital at the University of Michigan about her recent essay on this vital topic. https://doi.org/10.1007/s00246-023-03144-7

This week we delve into the world of the single ventricle when we speak with Dr. David Hoganson, Assistant Professor of Surgery at Harvard Medical School about a recent work he co-published with investigators from Boston Children's Hospital on computational fluid dynamic modeling in the planning of the Fontan operation. Single ventricle heterotaxy patients with interrupted IVC are at enhanced risk for the development of pulmonary AVM's due to flow maldistribution to the pulmonary arteries from the hepatic veins in a Fontan. Can a computational fluid dynamic model predict which operative approach would result in the most balanced hepatic venous flow distribution? Can this reduce the incidence of pulmonary AVM's? How well did the models predict the actual pulmonary flow measured after surgery on CMR? Who beyond the heterotaxy patient might benefit from this approach? Dr. Hoganson offers us a peek into the world of personalized surgery in this week's exciting episode.         DOI: 10.1016/j.jacadv.2024.101057

This week we turn back the clocks to re-review a recent research letter from the team at the Harvard Congenital Heart Program about venous insufficiency in the Fontan patient. Why do patients with Fontan circulation develop chronic venous insufficiency and what are the implications of this problem in the Fontan patient? What sort of evaluation should be performed on the Fontan patient presenting with lower extremity venous changes? How worried should the cardiologist be when presented with a Fontan patient with these changes? These are amongst the questions reviewed on this topic with this week's guest, Associate Professor at Baylor University, Dr. Tony Pastor.JACC Adv 2022 Mar, 1 (1) 100002

This week we review a recent report assessing LV function and properties in the Ebstein's anomaly patient using CMR. How often is LV dysfunction observed in the Ebstein's patient who is about to undergo surgical Cone repair? How often did the echo underestimate LV dysfunction in comparison to the 'gold standard' CMR? How often is LV non-compaction observed when using strict criteria in this disease? Can CMR assessment of LV function preoperatively predict postoperative ICU course? These are amongst the questions posed to the first author of this week's work, advanced imaging fellow at U. Pittsburgh, Dr. Aditi Gupta. https://doi.org/10.1007/s00246-024-03585-8

This week we delve into the world of electrophysiology and review a recent report from the team at Primary Children's hospital on the use of intravascular ultrasound for EP ablation procedures in children. How is this technology useful for ‘routine' ablations in kids? Are there some forms of tachycardia where its use is more important than others? How does it lower procedural time or improve efficacy? We speak with Dr. Thomas Pilcher, chief of pediatric electrophysiology at Primary Children's about his center's recent report in the use of this technology for ablation in children and those with congenital heart disease. https://doi.org/10.1093/europace/euae047

This past week marked the passing of the great pediatric cardiology pioneer, Dr. Sylvia Griffiths. Dr. Griffiths was a trainee of Dr. Ruth Wittemore of Yale University and was one of the founders of the pediatric cardiology program at NY Presbyterian Hospital in the mid 1950's with Dr. Sidney Blumenthal. Her career spanned 7 decades, all at NY Presbyterian, Columbia University. She is remembered as a pioneering woman in medicine as well as a pioneer as a pediatric cardiologist. She is also remembered as a kind and warm colleague and friend. In today's 304th episode of Pediheart we review a 55 year old paper by Dr. Griffiths on outcomes of partial AV canal repair and speak with the present chief of pediatric cardiology at NY Presbyterian, Dr. Christopher Petit about the important role she played at Columbia. We then speak with Professor of Pediatrics at the Albert Einstein College of Medicine, Dr. Christine Walsh about the role she played in Dr. Walsh's life as well as the lives of so many patients, colleagues and friends. Her imprint will remain and she will always be missed and remembered fondly by all. DOI: 10.1161/01.cir.40.1.21

This week we review a recent paper from last 2023 about outcomes of cardiac transplantation in the adult congenital heart patient (ACHD). Little has been written on this topic until this very robust and large scale report. How do single ventricle ACHD patients fair at transplant and how do they compare to non-ACHD heart transplant recipients? Why might 1 and 3 year outcomes not be a 'fair' method of assessing outcomes in this very high risk patient group? How do HLHS patient outcomes compare with other single ventricles? Are there better ways to measure risk in this patient group and how might the data in this work inform risk stratification and management of failing Fontan patients in whom transplantation is being considered? These are amongst the questions posed this week to the week's expert, Dr Daphne Hsu who is Professor of Pediatrics at the Albert Einstein College of Medicine at The Children's Hospital at Montefiore. https://doi.org/10.1016/j.jacc.2023.06.037For those interested in learning more about Dr. Hsu, take a listen to episode #166 from June, 2021:https://www.spreaker.com/episode/pediheart-podcast-166-a-conversation-with-professor-daphne-hsu--45144274

This week we go back in time to 20222 to re-review an episode focusing on gender disparities in salary in the field of congenital electrophysiology. To what degree are female electrophysiologists paid less than their male counterparts despite similar levels of education, work effort and seniority? What interventions could be enacted to help 'mind the gap' and level the playing field in this regard? We speak with the chief of pediatric electrophysiology at The Children's Hospital of Philadelphia, Professor Maully Shah, who is the first author of this week's research letter. doi: 10.1016/j.jacep.2022.02.011

This week's topic is ductal stenting in a low resource environment. We review a recent report from the team at Amrita Institute in Kerala, India about their large, over 10 year experience in ductal stenting. Why has this approach superceded BTTS in this environment? How does the team determine if a patient is a candidate and what morphologies of duct would be inappropriate for intervention? How does the team manage PGE prior to ductal stenting to allow that perfect balance between pulmonary blood flow and ductal constriction to improve procedural success? What can operators in the west learn from the experience of these operators? We review these questions and more with the first author of this work, Dr. Navaneetha Sasikumar who is Associate Professor of Pediatrics at the Amrita Institute.DOI: 10.1007/s00246-024-03496-8